Sinusitis Treatment Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.40 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Sinusitis Treatment Market Analysis
The Sinusitis Treatment Market is projected to register a CAGR of 6.4% during the forecast period.
The COVID-19 pandemic had an effect on the market. The outbreak of COVID-19 infections in the global population was expected to be associated with sinusitis infections in the infected patients, thereby driving the growth of the market. The article published in the National Library of Medicine in May 2021 mentioned that patients diagnosed with acute invasive fungal rhino-sinusitis associated with recent COVID-19 infection and treated at Manusora University were analyzed. All patients had a definite diagnosis of COVID-19 by PCR and CT studies with post-COVID invasive fungal sinusitis. As a result, during the pandemic, the Sinusitis Treatment Market is expected to grow because of the increased demand for effective treatment.
Sinusitis can be acute or chronic, with different germs such as bacteria and viruses blocking the nasal cavities or filling them with fluid if not treated. Sinusitis can progress to complications such as a brain abscess and meningitis if it is not treated or detected. Blood tests, ciliary function tests, nasal cytology & allergy testing, sinus CT scans, and sinus MRIs are all available for diagnostic purposes. Antibiotics are the first line of treatments followed by decongestants and surgery at a severe stage.
Market growth can be attributable to a variety of factors, including the rising prevalence rate of sinusitis, increased demand for diagnostic tests and antibiotics, and technological advancements in sinusitis surgery.
Additionally, the growing use of medical devices for disease diagnosis and treatment, as well as the use of various medications for treatment such as nasal sprays, nasal corticosteroids, and decongestants, are key parameters in the unprecedented growth of the sinusitis treatment market during the forecast period. According to the article titled ' Chronic Sinusitis' published in June 2021, corticosteroids are frequently utilized in the treatment of people with chronic sinusitis. Large-volume corticosteroid irrigation helps patients with chronic sinusitis after sinus surgery.
The primary strategies of the companies in this market are new product launching to find out better solution for sinusitis treatment. For instance, according to Clinic Barcelona 2021, monoclonal antibodies are effective form of precision medicine in sinusitis with polyps and different clinical trials have been carried out with the drugs omalizumab (IgE), mepolizumab (IL-5), reslizumab (IL-5) and dupilumab (IL4 α) to know there effectiveness. In May 2020, Nasus Medical, a startup born out of Stanford Biodesign and now a Fogarty Institute company, is working on a solution for better intra-nasal drug delivery. When the first signs of chronic sinusitis arise, their novel device promises to allow patients to treat themselves at home.
Thus the above-mentioned factors are exected to drive the growth of the market during the forecast period.
Sinusitis Treatment Market Trends
This section covers the major market trends shaping the Sinusitis Treatment Market according to our research experts:
Antibiotics Segment is Anticipated to Show Considerable Growth During the Forecast Period
Analgesics, Antihistamines, Corticosteroids, Antibiotics, and Surgery are among the treatments available in the global sinusitis treatment market. Antibiotics are recommended for bacterial sinusitis involving the frontal, sphenoid, or ethmoid sinuses, as this type of sinusitis can produce more serious problems. Antibiotics like Penicillins, cephalosporins, and macrolides have been recommended for a long time. According to the article published in the National Library of Medicine in August 2022 Antibiotics may be prescribed when symptoms of a sinus infection warrant such treatment. Common antibiotics for sinus infection include Augmentin, Zithromax, Levaquin, Septra, and Amoxil.
Similarly, the article published in the National Library of Medicine in February 2021 mentioned that the prevalence rate of chronic sinusitis is around 10.9% in Europe, 13% in the United States, 6.95% in South Korea, and 8% in China, which may lead to increased demand of antibiotics. For a better treatment of acute sinusitis in adults, there is a need to rethink the current approach to treatment. The development of new therapies and drugs would require lots of time, effort, scientific research, and capital. As a result, players are stepping up their R&D efforts to provide better alternative solutions for treating patients suffering from sinusitis.
North America is Expected to have Significant Market Share in the Sinusitis Treatment Market Over the Forecast Period
North America accounted for a significant share of the sinusitis treatment market because of the high prevalence rate of sinusitis.
As per the article titled ' Sinusitis' published in May 2022, sinusitis is one of the most common reasons for clinical visits in the United States and leads to 73 million restricted-activity days over one year. In addition, the health awareness and active presence of significant players are expected to fuel the market growth in this region. For instance, in March 2021 the United States Food and Drug Administration expanded the use of ClearUp sinus Pain relief treatment to include indications for treating congestion.
Clinical trials are another factor in market growth. For instance, in July 2022, St. Paul's Hospital, Canada launched a randomized, double-blind, placebo-controlled trial of 80 subjects to test whether a sinus power wash plus sinonasal microbiota transfer (SNMT) improves clinical outcomes in chronic sinusitis (CRS) patients within 45 days compared to a sinus power wash and sham SNMT. The investigators investigated the safety profile of SNMT to determine if SNMT-related CRS symptom improvement lasts up to 6 months. Finally, the investigators investigated how SNMT contributes to CRS recovery, by tracking changes in the sinus microbiota and inflammation pre-and post-treatment. Thus, such clinical trials are expected to provide better treatment in the region which is expected to increase the market growth.
Thus, the increasing prevalence of sinusitis, awareness campaigns, and clinical trials are expected to increase market growth over the forecast period.
Sinusitis Treatment Industry Overview
The Sinusitis Treatment Market is fragmented. Major companies in the Sinusitis Treatment market are Olympus Corporation, Medtronic plc, Stryker, Cipla Ltd., Dr. Reddy's Laboratories Ltd, Intersect ENT, Inc., Sanofi SA, and Aurobindo Pharma among others.
Sinusitis Treatment Market Leaders
-
Olympus Corporation
-
Medtronic plc
-
Cipla Inc.
-
Dr. Reddy’s Laboratories Ltd.
-
Stryker Corporation
*Disclaimer: Major Players sorted in no particular order
Sinusitis Treatment Market News
- In July 2022, Optinose released the results of pre-planned analyses from the ReOpen trial program evaluating XHANCE for the treatment of patients with chronic sinusitis. XHANCE (fluticasone propionate) nasal spray is a drug-device combination product combining its proprietary Exhalation Delivery System (EDS) designed to uniquely deliver drugs high and deep in nasal passages with an anti-inflammatory drug.
- In August 2021 GlaxoSmithKline received Food and Drug Administration approval for Nucala (mepolizumab), for the treatment of Chronic Rhinosinusitis with nasal polyps.
Sinusitis Treatment Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence Rate of Sinusitis
4.2.2 Increased Demand for Diagnostic Tests and Antibiotics
4.2.3 Technological Advancements in Sinusitis Surgery
4.3 Market Restraints
4.3.1 Use of Generic Drugs in Global Market
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Disease
5.1.1 Acute Sinusitis
5.1.2 Sub-acute Sinusitis
5.1.3 Chronic Sinusitis
5.2 By Treatment
5.2.1 Analgesics
5.2.2 Antihistamines
5.2.3 Corticosteroids
5.2.4 Antibiotics
5.2.5 Surgery
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Olympus Corporation
6.1.2 Medtronic plc
6.1.3 Stryker Corporation
6.1.4 Cipla Ltd.
6.1.5 Dr. Reddy's Laboratories Ltd
6.1.6 Sanofi SA
6.1.7 Aurobindo Pharma
6.1.8 Smith & Nephew PLC
6.1.9 Novartis AG
6.1.10 GlaxoSmithKline PLC
6.1.11 Teva Pharmaceutical Industries Ltd
6.1.12 Bayer AG
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Sinusitis Treatment Industry Segmentation
As per the scope of this report, sinusitis is a condition in which the mucosal lining of the paranasal sinuses becomes inflamed. However, because sinusitis is always accompanied by inflammation of the neighboring nasal mucosa, the term rhinosinusitis is more accurate. Blockage of the sinus ostium, usually the maxillary sinus ostium under the middle turbinate, appears to be the triggering element in acute sinusitis. Sinusitis must be treated well as it can lead to complications like brain abscess and meningitis. The Sinusitis Treatment Market is Segmented by Disease (Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis), Treatment (Analgesics, Antihistamines, Corticosteroids, Antibiotics, Surgery), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Disease | |
| Acute Sinusitis | |
| Sub-acute Sinusitis | |
| Chronic Sinusitis |
| By Treatment | |
| Analgesics | |
| Antihistamines | |
| Corticosteroids | |
| Antibiotics | |
| Surgery |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Sinusitis Treatment Market Research FAQs
What is the current Global Sinusitis Treatment Market size?
The Global Sinusitis Treatment Market is projected to register a CAGR of 6.40% during the forecast period (2024-2029)
Who are the key players in Global Sinusitis Treatment Market?
Olympus Corporation, Medtronic plc, Cipla Inc., Dr. Reddy’s Laboratories Ltd. and Stryker Corporation are the major companies operating in the Global Sinusitis Treatment Market.
Which is the fastest growing region in Global Sinusitis Treatment Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Sinusitis Treatment Market?
In 2024, the North America accounts for the largest market share in Global Sinusitis Treatment Market.
What years does this Global Sinusitis Treatment Market cover?
The report covers the Global Sinusitis Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Sinusitis Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Sinusitis Treatment Industry Report
Statistics for the 2024 Sinusitis Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sinusitis Treatment analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
